Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 597  

    Article Cited by others

ORIGINAL ARTICLE

99m Tc glucarate as a potential radiopharmaceutical agent for assessment of tumor viability: From bench to the bed side

Choudhury Partha S, Savio E, Solanki K K, Alonso O, Gupta A, Gambini J P, Doval Dinesh, Sharma P, Dondi M

Year : 2012| Volume: 11| Issue : 2 | Page no: 47-56

   This article has been cited by
 
1 Conceptual design of direct 99mTc production facility at the high temperature engineering test reactor
Hai Quan Ho,Hiroki Ishida,Shimpei Hamamoto,Toshiaki Ishii,Nozomu Fujimoto,Naoyuki Takaki,Etsuo Ishitsuka
Nuclear Engineering and Design. 2019; 352: 110174
[Pubmed]  [Google Scholar] [DOI]
2 Updated developments on molecular imaging and therapeutic strategies directed against necrosis
Dongjian Zhang,Meng Gao,Qiaomei Jin,Yicheng Ni,Jian Zhang
Acta Pharmaceutica Sinica B. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 Avenues to molecular imaging of dying cells: Focus on cancer
Anna A. Rybczynska,Hendrikus H. Boersma,Steven de Jong,Jourik A. Gietema,Walter Noordzij,Rudi A. J. O. Dierckx,Philip H. Elsinga,Aren van Waarde
Medicinal Research Reviews. 2018;
[Pubmed]  [Google Scholar] [DOI]
4 Imaging of isoproterenol-induced myocardial injury with F-18-labeled fluoroglucaric acid in a rat model
Hailey A. Houson,Gregory N. Nkepang,Andria F. Hedrick,Vibhudutta Awasthi
Nuclear Medicine and Biology. 2017;
[Pubmed]  [Google Scholar] [DOI]
5 Patent highlights June–July 2016
Hermann AM Mucke
Pharmaceutical Patent Analyst. 2016;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article